TCL Archive Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA May 23, 1986
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive DCT to Fund 11 Surgical Oncology Grants. Consider Switching $700,000 To Program Project Renewals November 2, 1979